-
681
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors
Published 2022-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
682
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells
Published 2021-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
683
Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update
Published 2024-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
684
Trojan-horse silk fibroin nanocarriers loaded with a re-call antigen to redirect immunity against cancer
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
685
CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1–CXCR2 induced NETs
Published 2024-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
686
Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
Published 2022-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
687
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
688
Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer
Published 2022-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
689
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
690
Role of Fcγ receptors in HER2-targeted breast cancer therapy
Published 2022-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
691
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
692
Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment
Published 2023-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
693
Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma
Published 2021-04-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
694
Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
695
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
696
Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
697
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metast...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
698
Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided ca...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
699
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
700
Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
Published 2019-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article